A Dual Role for Sirtuin 1 in Tumorigenesis

E-ISSN： 1873-4286|20|15|2634-2636

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.15, 2014-05, pp. : 2634-2636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis is a Link Between Atherosclerosis and Tumorigenesis: Role of LOX-1

By Jiang Junlin

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 5, 2011-10 ,pp. : 461-468

Springer Publishing Company

Access to resources Recommend Favorite

Sirtuin-1 and HIV-1: An Overview

Current Drug Targets, Vol. 14, Iss. 6, 2013-06 ,pp. : 648-652

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Epithelial Mesenchymal Transition in Prostate Tumorigenesis

Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. : 1240-1248

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas

Current Cancer Drug Targets, Vol. 15, Iss. 6, 2015-01 ,pp. : 463-468

Bentham Science Publishers

Access to resources Recommend Favorite

The expanding role of H₁ antihistamines: a patent survey of selective and dual activity compounds 2005 – 2010

By Beaton Graham Moree Wilna J

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. : 1197-1218

Informa Healthcare

Access to resources Recommend Favorite